Clinical Trial: ECOG-ACRIN EA8191

ECOG-ACRIN EA8191

Status: Open

Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients with Post-ProstaTEctomy Biochemical Recurrence (INDICATE)

EA8191, Arms A and B are closed to accrual, effective January 31, 2025.

Eligible for screening study DCP 001

Completion of Pre-Registration QOLs is required after consent, prior to registration. Please see study documents.